Mesa Laboratories, Inc. (MLAB) Fair Value 2026

MLAB · Scientific & Technical Instruments ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

8.5 /10

32 fundamental signals · 9 models active

Value Trap Risk

LOW (29/100)

Quick Summary — As of 2026-08-27, Mesa Laboratories, Inc. (MLAB) trades at $128.65, versus a $80.46 median fair value across its 9 active models — 37.5% below the current price. QOC: 8.5/10. Value Trap Risk: 29/100 (LOW). 9/13 models active. Within that set, the Bayesian DCF component alone returns $88.75.

Key Facts

Ticker
MLAB
Price
$128.65
Quality Score
8.5/10
Value Trap Risk
29/100
Models Active
9/13
Last Updated
Strength: Quality Score of 8.5/10 indicates strong fundamentals
Risk: Majority of models suggest overvaluation

Is Mesa Laboratories, Inc. (MLAB) Undervalued or Overvalued in 2026?

According to CirclFi’s 9-model valuation engine, Mesa Laboratories, Inc. (MLAB) appears overvalued as of : the median of 9 independent fair value estimates is $80.46, 37.5% below the current price of $128.65. Estimates range from $5.57 to $206.76. MLAB scores 8.5/10 on fundamental quality and 29/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. MLAB’s -37.5% gap is wider than that market norm, and the Scientific & Technical Instruments sector median is -44.5%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Mesa Laboratories, Inc. Stock in 2026? →

What Fair Value Does Each Model Give MLAB?

9 Intrinsic Value Models vs. Current Price ($128.65)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $88.75 -31.0%
Ensemble · Low Conviction
 $69.33 -46.1%
Scenario · High Conviction
 $80.46 -37.5%
Intrinsic · High Conviction
 $20.13 -84.4%
Unlock the Full Matrix

Access 5 additional models including Markov DDM, Regime Cross-Sectional, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 9 Models →

Cancel anytime · No contracts · Instant access

What Is MLAB's Fair Value Range?

Spread across 9 independent models · $5.57 to $206.76

CirclFi's 9 active models place Mesa Laboratories, Inc. (MLAB) between $5.57 and $206.76 per share, a spread of 250% of the median. The median of that range — $80.46 — is the fair value CirclFi publishes for MLAB, against a current price of $128.65.

Low · Markov DDMHigh · Regime Cross
$5.57median $80.46$206.76
Where the range comes from
Most bearish modelMarkov DDM$5.57
Most bullish modelRegime Cross-Sectional$206.76
Model agreement1 bullish · 8 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for MLAB. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on MLAB, not a CirclFi price target. How each model works →

What Is Mesa Laboratories, Inc. (MLAB) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Mesa Laboratories, Inc.'s intrinsic value is estimated at $80.46. Trading at its current price of $128.65, the valuation engine raises significant caution: 8 of 9 models flag downside risk, projecting a median implied return of -37.5%. Model dispersion is worth noting: Regime Cross targets $206.76 (+60.7%), versus Markov DDM at $5.57 (-95.7%). This +156.4% range highlights the importance of multi-model analysis rather than relying on any single methodology. Among models with highest confidence, Bayesian DCF lean bearish — adding weight to the bearish side of the thesis.

What Do the Models Say About MLAB?

9 of 13 models are currently active for MLAB. Of these, 1 model suggests upside while 8 models suggest overvaluation. Taken together, their median fair value for MLAB is $80.46 — the figure CirclFi publishes as this stock's fair value. One component of that median, the Bayesian DCF, returns $88.75 on its own, implying -31.0% downside from the current price. See which stocks rank higher →

How Does MLAB Rank in Scientific & Technical Instruments?

Among 40 Scientific & Technical Instruments stocks, MLAB ranks #9 by Quality of Company score. CirclFi's QOC score of 8.5/10 evaluates 32 fundamental signals. A score of 8.5 places MLAB in the top tier.

Mesa Laboratories, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is MLAB a Value Trap?

CirclFi's Value Trap algorithm assigns MLAB a score of 29/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

9 of 13 models are active for Mesa Laboratories, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, Mesa Laboratories, Inc. earns a quality score of 8.5/10. This robust rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

The gap between the most bullish and bearish model spans +156.4% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every MLAB valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across MLAB's 9 active models, average confidence is 53%. Moderate confidence indicates reasonable fit.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Mesa Laboratories, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Scientific & Technical Instruments Stocks Should You Also Analyze?

11 related Scientific & Technical Instruments stocks with 13-model coverage

AATCAutoscope Technologies CorporationQOC 8.5ITRIItron, Inc.QOC 8.5SOTKSono-Tek CorporationQOC 8.6CGNXCognex CorporationQOC 8.3ESEESCO Technologies Inc.QOC 8.7NOVTNovanta Inc.QOC 8.2LGLThe LGL Group, Inc.QOC 7.1SCNDScientific Industries, Inc.QOC 5.4ITRNIturan Location and Control Ltd.QOC 3.0ACFNAcorn Energy, Inc.QOC 9.4BMIBadger Meter, Inc.QOC 9.3

Read investment analysis: AATC · ITRI · SOTK · CGNX · ESE · NOVT · LGL · SCND · ITRN · ACFN · BMI

Which Other Stocks Have a Similar Quality Score to MLAB?

7 companies across all industries closest to MLAB’s Quality of Company score of 8.5/10.

SANMSanmina CorporationQOC 8.5GNTXGentex CorporationQOC 8.5VCVisteon CorporationQOC 8.5TTEKTetra Tech, Inc.QOC 8.5AVNWAviat Networks, Inc.QOC 8.5PCARPACCAR IncQOC 8.5NVDANVIDIA CorporationQOC 10.0

Read investment analysis: SANM · GNTX · VC · TTEK · AVNW · PCAR · NVDA

What Else Do Investors Ask About Mesa Laboratories, Inc.’s Valuation?

What is Mesa Laboratories, Inc.'s intrinsic value in 2026?

CirclFi puts Mesa Laboratories, Inc. (MLAB)'s intrinsic value at $80.46 — the median of 9 independent model estimates as of 2026-08-27, ranging from $5.57 to $206.76. One component of that median, the Bayesian DCF, runs 10,000 Monte Carlo simulations with jump-diffusion and returns $88.75 on its own. The Quality of Company score is 8.5/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is MLAB overvalued or undervalued right now?

At $128.65, 1 of 9 active models suggest MLAB may be undervalued, while 8 indicate potential overvaluation. The median of all 9 fair value estimates is $80.46, 37.5% below the current price of $128.65 — a consensus view that MLAB is overvalued. The assessment depends on which methodology best fits Mesa Laboratories, Inc.'s business model in Scientific & Technical Instruments.

What does a Quality of Company score of 8.5 mean for MLAB?

Mesa Laboratories, Inc.'s QOC of 8.5/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on MLAB?

CirclFi analyzes MLAB with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 9 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on MLAB?

Of the 9 models currently active on MLAB, Regime Cross-Sectional is the most bullish at $206.76 per share, and Markov DDM is the most bearish at $5.57. CirclFi's published fair value for MLAB is the median of that range, $80.46, not either extreme. The gap between the two ends equals 250% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is MLAB a value trap in 2026?

Mesa Laboratories, Inc.'s Value Trap score is 29/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 9-model valuation engine, Mesa Laboratories, Inc. (MLAB) has a median fair value of $80.46 — 37.5% below the current price of $128.65 — as of 2026-08-27.” Source: circlfi.com/stock/MLAB/ · Methodology
Primary sources for this MLAB valuation
  • Financial statements: Mesa Laboratories, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0000724004) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for MLAB as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 9 mathematical frameworks give you clarity on MLAB.

Unlock All 9 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

5 models hidden for MLAB Unlock All 9 — $39/mo